Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Chromosomal 3q amplicon encodes essential regulators of secretory vesicles that drive secretory addiction in cancer
Xiaochao Tan, … , William K. Russell, Jonathan M. Kurie
Xiaochao Tan, … , William K. Russell, Jonathan M. Kurie
Published April 25, 2024
Citation Information: J Clin Invest. 2024;134(12):e176355. https://doi.org/10.1172/JCI176355.
View: Text | PDF
Research Article Cell biology Oncology

Chromosomal 3q amplicon encodes essential regulators of secretory vesicles that drive secretory addiction in cancer

  • Text
  • PDF
Abstract

Cancer cells exhibit heightened secretory states that drive tumor progression. Here, we identified a chromosome 3q amplicon that serves as a platform for secretory regulation in cancer. The 3q amplicon encodes multiple Golgi-resident proteins, including the scaffold Golgi integral membrane protein 4 (GOLIM4) and the ion channel ATPase secretory pathway Ca2+ transporting 1 (ATP2C1). We show that GOLIM4 recruited ATP2C1 and Golgi phosphoprotein 3 (GOLPH3) to coordinate Ca2+-dependent cargo loading, Golgi membrane bending, and vesicle scission. GOLIM4 depletion disrupted the protein complex, resulting in a secretory blockade that inhibited the progression of 3q-amplified malignancies. In addition to its role as a scaffold, GOLIM4 maintained intracellular manganese (Mn) homeostasis by binding excess Mn in the Golgi lumen, which initiated the routing of Mn-bound GOLIM4 to lysosomes for degradation. We show that Mn treatment inhibited the progression of multiple types of 3q-amplified malignancies by degrading GOLIM4, resulting in a secretory blockade that interrupted prosurvival autocrine loops and attenuated prometastatic processes in the tumor microenvironment. As it potentially underlies the selective activity of Mn against 3q-amplified malignancies, ATP2C1 coamplification increased Mn influx into the Golgi lumen, resulting in a more rapid degradation of GOLIM4. These findings show that functional cooperativity between coamplified genes underlies heightened secretion and a targetable secretory addiction in 3q-amplified malignancies.

Authors

Xiaochao Tan, Shike Wang, Guan-Yu Xiao, Chao Wu, Xin Liu, Biyao Zhou, Yu Jiang, Dzifa Y. Duose, Yuanxin Xi, Jing Wang, Kunika Gupta, Apar Pataer, Jack A. Roth, Michael P. Kim, Fengju Chen, Chad J. Creighton, William K. Russell, Jonathan M. Kurie

×

Figure 2

GOLIM4 is a protumorigenic effector of the 3q amplicon.

Options: View larger image (or click on image) Download as PowerPoint
GOLIM4 is a protumorigenic effector of the 3q amplicon.
(A and B) Correl...
(A and B) Correlation analyses of 3q-amplified (red) and -diploid (black) lung cancer cell lines. (A) GOLIM4 copy numbers, mRNA levels (left plot), and protein levels (right plot) from the CCLE database. (B) qRT-PCR analysis of GOLIM4 copy numbers (CN) and mRNA levels. (C) WB analysis of GOLIM4 protein levels in cell lines. NL, normal lung epithelial cells. (D) WB confirmation of target gene depletion in shRNA-transfected H1299 cells. GOLIM4 (shGOLIM4) and control (shCTL) shRNAs were used. (E and F) Orthotopic lung tumor sizes and distant metastasis numbers generated by shRNA-transfected H1299 cells (E) or H520 cells (F) and images of H&E-stained lung sections (E). Scale bar: 4 mm. Arrows indicate tumors. (G) Kaplan-Meier survival analysis of orthotopic H520 tumor–bearing mice. (H) WB confirmation of target gene depletion by CRISPR/Cas9-mediated gene editing in H1299 cells. (I) Sizes of flank tumors generated by the cells in H. Parental (H1299). (J) Size of flank tumors generated by the cells in D. (K) Primary tumor sizes and lung metastasis numbers generated by subcutaneously injected parental and GOLIM4-KO 344SQ cells. Data indicate the mean ± SD from a single experiment incorporating biological replicate samples (n = 3, unless otherwise indicated) and are representative of at least 2 independent experiments. ***P < 0.001, by 1-way ANOVA (E and F), log-rank test (G), or 2-tailed Student’s t test (I–K).

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts